These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29421217)

  • 1. D-Optimal Design in the Development of Rheologically Improved In Situ Forming Ophthalmic Gel.
    Krtalić I; Radošević S; Hafner A; Grassi M; Nenadić M; Cetina-Čižmek B; Filipović-Grčić J; Pepić I; Lovrić J
    J Pharm Sci; 2018 Jun; 107(6):1562-1571. PubMed ID: 29421217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical efficacy of cosmeceutical application of liquid crystalline nanostructured dispersions of alpha lipoic acid as anti-wrinkle.
    Sherif S; Bendas ER; Badawy S
    Eur J Pharm Biopharm; 2014 Feb; 86(2):251-9. PubMed ID: 24056055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid thermosensitive-mucoadhesive
    Fathalla Z; Mustafa WW; Abdelkader H; Moharram H; Sabry AM; Alany RG
    Drug Deliv; 2022 Dec; 29(1):374-385. PubMed ID: 35068268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheological evaluation of poloxamer as an in situ gel for ophthalmic use.
    Edsman K; Carlfors J; Petersson R
    Eur J Pharm Sci; 1998 Apr; 6(2):105-12. PubMed ID: 9795025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
    Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermoreversible in situ gelling poloxamer-based systems with chitosan nanocomplexes for prolonged subcutaneous delivery of heparin: design and in vitro evaluation.
    Radivojša M; Grabnar I; Ahlin Grabnar P
    Eur J Pharm Sci; 2013 Sep; 50(1):93-101. PubMed ID: 23524253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular poloxamer-based ciprofloxacin hydrochloride in situ forming gels.
    Mansour M; Mansour S; Mortada ND; Abd Elhady SS
    Drug Dev Ind Pharm; 2008 Jul; 34(7):744-52. PubMed ID: 18612913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New method for ophthalmic delivery of azithromycin by poloxamer/carbopol-based in situ gelling system.
    Cao F; Zhang X; Ping Q
    Drug Deliv; 2010; 17(7):500-7. PubMed ID: 20500130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
    Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
    Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poloxamer/cyclodextrin/chitosan-based thermoreversible gel for intranasal delivery of fexofenadine hydrochloride.
    Cho HJ; Balakrishnan P; Park EK; Song KW; Hong SS; Jang TY; Kim KS; Chung SJ; Shim CK; Kim DD
    J Pharm Sci; 2011 Feb; 100(2):681-91. PubMed ID: 20803575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies.
    M A Fathalla Z; Vangala A; Longman M; Khaled KA; Hussein AK; El-Garhy OH; Alany RG
    Eur J Pharm Biopharm; 2017 May; 114():119-134. PubMed ID: 28126392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preparation and properties of thermosensitive in situ gel for ophthalmic formulation containing pearl hydrolyzate].
    Song LN; Li HR; Wang HY; Li Z; Zhao WC; Lu FZ; Li SM
    Yao Xue Xue Bao; 2016 Oct; 51(10):1622-8. PubMed ID: 29932618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan in situ gelation for improved drug loading and retention in poloxamer 407 gels.
    Ur-Rehman T; Tavelin S; Gröbner G
    Int J Pharm; 2011 May; 409(1-2):19-29. PubMed ID: 21335076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified thermoresponsive Poloxamer 407 and chitosan sol-gels as potential sustained-release vaccine delivery systems.
    Kojarunchitt T; Baldursdottir S; Dong YD; Boyd BJ; Rades T; Hook S
    Eur J Pharm Biopharm; 2015 Jan; 89():74-81. PubMed ID: 25481034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on preparation of Dange Mingmu in-situ forming eye gel].
    Wang Z; Wang Y; Li H; Zang C; Zhang B
    Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):46-51. PubMed ID: 22741460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels.
    He W; Guo X; Feng M; Mao N
    Int J Pharm; 2013 Dec; 458(2):305-14. PubMed ID: 24409520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temperature-responsive, Pluronic-g-poly(acrylic acid) copolymers in situ gels for ophthalmic drug delivery: rheology, in vitro drug release, and in vivo resident property.
    Ma WD; Xu H; Nie SF; Pan WS
    Drug Dev Ind Pharm; 2008 Mar; 34(3):258-66. PubMed ID: 18363141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation, functional evaluation and ex vivo performance of thermoresponsive soluble gels - A platform for therapeutic delivery to mucosal sinus tissue.
    Pandey P; Cabot PJ; Wallwork B; Panizza BJ; Parekh HS
    Eur J Pharm Sci; 2017 Jan; 96():499-507. PubMed ID: 27771516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels.
    Asasutjarit R; Thanasanchokpibull S; Fuongfuchat A; Veeranondha S
    Int J Pharm; 2011 Jun; 411(1-2):128-35. PubMed ID: 21459137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery.
    Gratieri T; Gelfuso GM; Rocha EM; Sarmento VH; de Freitas O; Lopez RF
    Eur J Pharm Biopharm; 2010 Jun; 75(2):186-93. PubMed ID: 20188828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.